RVP Retractable Technologies Inc. Total Debt to Capital

RVP (retractable.com) - company brandmark

Retractable Technologies (RVP) is concluding its period of pandemic-driven volumes and transitioning toward providing stable supplies to US clinics. Market price action for the total debt-to-equity ratio stands at 0.01. The business relies on the implementation of VanishPoint secure systems, which foster strong loyalty among medical personnel. Meanwhile, profits depend on government contracts in conflict zones and the availability of polymers, the costs of which fluctuate due to trade disputes.

Retractable Technologies Inc. (RVP) - Total Debt to Capital Coefficient from 07/04/2022 to 10/28/2026
Finished products of Retractable Technologies Inc.

A professional investor assesses asset stability through the balance of debt and equity, utilizing this ratio to determine the degree of financial risk. By analyzing the company's leverage relative to equity, you see the proportion of total liabilities to net assets, which is critical for Retractable Technologies (RVP): the patent protection of the VanishPoint technology allows the company to minimize its debt load while maintaining a high market valuation of the business.

Main competitors

Total Debt to Capital ISRG (Intuitive)|Debt to Capital Danaher Corporation|Total Debt to Capital Becton, Dickinson and Company BDX|Debt to Equity Ratio STERIS Group (STE)|Total Debt to Capital WST|Total Debt to Capital Coefficient baxter.com BAX|MASI: Total Debt to Capital|STVN - Total Debt to Equity Ratio|TFX: Total Debt to Capital|MMSI (Merit Medical Corp) - Total Debt to Capital|Debt to Equity Envista Holdings|Debt to Equity icumed.com (ICUI)|Dentsply Sirona (XRAY) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio LeMaitre Vascular Inc (LMAT)|Total Debt to Capital ATRC|STAAR Surgical Co - Total Debt to Capital Coefficient|ChromaDex Corp. (NAGE) - Debt to Equity|ZIMV: Debt to Equity Ratio|AngioDynamics - Debt to Equity|Total Debt to Capital Coefficient Cerus Corp.|Alpha Teknova Inc (TKNO) - Total Debt to Equity Ratio|Aggregate Debt to Capital MGRM|Sharps Technology, Inc. (STSS) - Debt to Equity|All Debt to Shareholders' Equity Ratio infusystem.com INFU|Total Debt to Equity Ratio UTMD (Utah Medical Products, Inc.)|KORU Medical Systems, Inc. - Total Debt to Capital|NYXH: Debt to Equity|MBOT - Total Debt to Equity Ratio|Total Debt to Capital PDEX|ZTEK (zentek.com) - Debt to Capital|Debt to Equity Elutia (ELUT)|Debt to Equity Ratio Milestone Scientific Inc (MLSS)|Total Debt to Equity Ratio NEXGEL, Inc|Aggregate Debt to Capital HBIO (harvardbioscience.com)|Debt to Equity FEMY|Meihua Medical Technologies - Total Debt to Capital Coefficient|Debt to Equity Predictive Oncology Corp (POAI)|CJMB - All Debt to Shareholders' Equity Ratio|Total Debt to Capital ATRI|Debt to Capital NeuroMetrix Corporation